Healthcare & Life Sciences

Incredo (formerly known as DouxMatok)

aliveseries-c-plus
series-c-plus
Stage
1
Investors

About

Incredo develops a sugar-based ingredient that enables up to 50% reduction of sugar content in food products while maintaining the taste and texture of natural sugar, aimed at healthier food formulations.

Explore Incredo (formerly known as DouxMatok)'s full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.